Abstract:Epilepsy Currents, Ahead of Print. Epilepsy-Associated SCN2A (NaV1.2) Variants Exhibit Diverse and Complex Functional Properties Thompson CH, Potet F, Abramova TV, DeKeyser JM, Ghabra NF, Vanoye CG, Millichap JJ, George AL. J Gen Physiol. 2023;155(10):e202313375. doi:10.1085/jgp.202313375. PMID: 37578743; PMCID: PMC10424433Pathogenic variants in neuronal voltage-gated sodium (NaV) channel genes including SCN2A, which encodes NaV1.2, are frequently discovered in neurodevelopmental disorders with and without epilepsy. SCN2A is also a high confidence risk gene for autism spectrum disorder (ASD) and nonsyndromic intellectual disability (ID). Previous work to determine the functional consequences of SCN2A variants yielded a paradigm in which predominantly gain-of-function (GoF) variants cause epilepsy whereas loss-of-function (LoF) variants are associated with ASD and ID. However, this framework is based on a limited number of functional studies conducted under heterogenous experimental conditions whereas most disease-associated SCN2A variants have not been functionally annotated. We determined the functional properties of more than 30 SCN2A variants using automated patch clamp recording to assess the analytical validity of this approach and to examine whether a binary classification of variant dysfunction is evident in a larger cohort studied under uniform conditions. We studied 28 disease-associated variants and 4 common population variants using two distinct alternatively spliced forms of NaV1.2 that were heterologously expressed in HEK293 T cells. Multiple biophysical parameters were assessed on 5,858 individual cells. We found that automated patch clamp recording provided a valid high throughput method to ascertain detailed functional properties of NaV1.2 variants with concordant findings for a subset of variants that were previously studied using manual patch clamp. Additionally, many epilepsy-associated variants in our study exhibited complex patterns of gain- and loss-of-function properties that are difficult to classify overall by a simple binary scheme. The higher throughput achievable with automated patch clamp enables study of a larger number of variants, greater standardization of recording conditions, freedom from operator bias, and enhanced experimental rigor valuable for accurate assessment of NaV channel variant dysfunction. Together, this approach will enhance our ability to discern relationships between variant channel dysfunction and neurodevelopmental disorders.

De Novo CLPTM1 Variants with Reduced GABAAR Current Response in Patients with Epilepsy

Clinical and Molecular Analysis of Epilepsy-Related Genes in Patients with Dravet Syndrome

De novo variants in KCNJ3 are associated with early-onset epilepsy

De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy

De novo GABRA1 variants in childhood epilepsies and the molecular subregional effects

Genotype-phenotype correlation in CLCN4-related developmental and epileptic encephalopathy

Analysis of epilepsy-associated variants in HCN3 - Functional implications and clinical observations

Novel Mutations and Phenotypes of Epilepsy-Associated Genes in Epileptic Encephalopathies.

Expanding the genetic and phenotypic relevance of CLCN4 variants in neurodevelopmental condition: 13 new patients

Identification and functional analysis of two new de novo KCNMA1 variants associated with Liang–Wang syndrome

GRIN2A Variants Associated with Idiopathic Generalized Epilepsies.

Loss-of-function variants in the KCNQ5 gene are implicated in genetic generalized epilepsies

Recurrent de novo single point variant on the gene encoding Na+/K+ pump results in epilepsy

Altered Inhibitory Synapses in De Novo GABRA5 and GABRA1 Mutations Associated with Early Onset Epileptic Encephalopathies.

High-throughput Evaluation of Epilepsy-associated KCNQ2 Variants Reveals Functional and Pharmacological Heterogeneity

Genotype and phenotype correlation of PHACTR1 -related neurological disorders

Mono and biallelic variants in cause severe neurodevelopmental disorders

Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate Genes

A Frameshift Variant of GluN2A Identified in an Epilepsy Patient Results in NMDA Receptor Mistargeting

DLG3 variants caused X-linked epilepsy with/without neurodevelopmental disorders and the genotype-phenotype correlation

No Pain, No Gain of Function: Epilepsy-Associated Variants in SCN2A Defy Classification